TREATMENT OF A PATIENT IN A RELAPSE AFTER BONE MARROW TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC LEUKEMIA WITH THE SYSTEMIC ADMINISTRATION OF ALLOGENEIC LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2-Reference-Cited by-同舟云学术

TREATMENT OF A PATIENT IN A RELAPSE AFTER BONE MARROW TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC LEUKEMIA WITH THE SYSTEMIC ADMINISTRATION OF ALLOGENEIC LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2

Published:2009-04-24 Issue:2 Volume:43 Page:184-185
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Komori Toshihisa,Sugiyama Haruo,Ogawa Hiroyasu,Oka Yoshihiro,Miyake Seigou,Soma Toshihiro,Tani Yoshihiko,Minami Yusaku,Kunisada Keita,Masaoka Tohru,Kishimoto Susumu

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.1989.tb00277.x/fullpdf

Reference4 articles.

1. In vitro growth of cytotoxic human lymphocytes. IV. Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T cell growth factor;Lotze;Cancer Res,1981

2. Lymphokine-activated killer cell phenomenon: lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes;Grimm;J Exp Med,1982

3. Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2;Lafreniere;Cancer Res,1985

4. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer;Rosenberg;N Engl J Med,1985

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Over-expression of aldehyde dehydrogenase-2 protects against H2O2-induced oxidative damage and apoptosis in peripheral blood mononuclear cells;Acta Pharmacologica Sinica;2011-02

2. Adoptive allogeneic immunotherapy – history and future perspectives;Transfusion Science;2000-10

3. The GVL Effect in Donor Lymphocyte Transfusion;Allogeneic Immunotherapy for Malignant Diseases;2000-01-27

4. Long-Term Follow-Up of Relapsed Acute Leukemia Treated with Immunotherapy After Allogeneic Transplantation: the Inseparability of Graft-Versus-Host Disease and Graft-Versus-Leukemia, and the Problem of Extramedullary Relapse;Leukemia & Lymphoma;1999-01

5. Graft-versus-host disease following interleukin-2/lymphokine-activated killer (LAK) cell immunotherapy in a patient with acute myelogenous leukaemia in second complete remission: autologous LAK cells following allogeneic bone marrow transplantation are donor-derived;Cancer Immunology Immunotherapy;1995-01